Budget Impact Model (Bim) Of Rivaroxaban In Comparison With Enoxaparin Plus Warfarin In The Treatment Of Venous Thromboembolism (Vte) Under The Perspective Of The Private Health System
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.828
https://www.valueinhealthjournal.com/article/S1098-3015(15)02904-6/fulltext
Title :
Budget Impact Model (Bim) Of Rivaroxaban In Comparison With Enoxaparin Plus Warfarin In The Treatment Of Venous Thromboembolism (Vte) Under The Perspective Of The Private Health System
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)02904-6&doi=10.1016/j.jval.2015.09.828
First page :
A383
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
268